e2e Pharma, a private label end-to-end manufacturer for CBD and non-CBD branded topicals and ingestibles that are sold direct to consumers online and through nationwide retail chains, is expanding the company’s fully operational, 30,000-square-foot manufacturing facility with four clean rooms
2023 Full-Year Financial Guidance1
The Company's full-year guidance for 2023 can be found in the table below. No updates were made to the previous guidance that was issued on February 23,